High-sensitivity troponin I: a novelty in cardiovascular prevention

Many people do not know this, but cardiovascular diseases are still the main cause of mortality in Italy and in the world, with a significant impact on the quality of life and on healthcare costs.

Scientific research is opening new perspectives on the prevention front, arriving at the early identification of those who, despite not presenting evident clinical signs, could be exposed to increased cardiovascular risk.

A Biomarker Ally in the Fight against Cardiovascular Disease: The New Role of Troponin I

The protagonist of this novelty is Troponin I , already known for its key role in the diagnosis of infarction and acute myocardial damage, and more recently the object of careful evaluation by the scientific community regarding its usefulness in cardiovascular prevention.

Troponin is a protein found in muscle tissue, particularly in the heart, where it plays an essential role in the contraction of muscle fibers.

Under normal conditions, its concentration in the blood is almost zero; however, in case of cardiac damage or suffering, troponin is released into the bloodstream, making it a specific indicator of heart health .

Recent international studies have highlighted the key role of troponin I not only in identifying and diagnosing cardiac events already underway, but also as a predictive tool in apparently healthy subjects.

Even minimal levels of this biomarker, detected with a new highly sensitive analytical method , are, in fact, able to detect the risk of experiencing an adverse cardiac event (such as ischemic stroke, heart attack, heart failure), together with the evaluation of other cardiovascular risk factors. This allows for targeted intervention , with in-depth diagnostic tests and prevention programs.

From diagnosis to prevention: a turning point for public health

The introduction of the highly sensitive Troponin I test in prevention pathways represents a significant turning point for public health.

The test, rapid and non-invasive - it is performed through a simple blood test - can be integrated into the periodic checks of the adult population. Reading the report requires the interpretation of your doctor or specialist, who will relate it to the clinical and diagnostic results and the evaluation of other cardiovascular risk factors (blood pressure, lipids, smoking, diabetes, family history).

The combined analysis of troponin I results and other risk factors allows to better identify subjects who need prevention and monitoring programs.

Prevention awareness: Glab campaign kicks off

Starting from Monday 30 June , it will be possible to access this innovative test as part of a campaign dedicated to cardiovascular prevention , promoted by Glab, the Clinical Analysis division of Cab , within the numerous blood collection points located throughout the area.

The cardiovascular risk stratification test can be booked online through the page dedicated to the Prevention Campaign, where all the practical information and access methods are available.

An opportunity, that of the exam, which is part of a broader path of health care, in which prevention becomes the key to reducing mortality and improving the quality of life.

Investing in prevention today for tomorrow's health

The availability of the new high-sensitivity Troponin I test marks a real step forward in the fight against cardiovascular disease , offering the population a concrete tool to know and manage their risk in a timely manner.

So, the invitation is open to all : book the test and rely on the qualified professionals at Cab for a personalized and cutting-edge prevention path.